Patient Characteristics and Percent Activity per Injected Dose at Myocardium
| Case | Age (y) | Sex | Route | Territory | Time from infarction (d) | CK (IU/mL) | CK-MB (ng/mL) | Injection dose (MBq) | Activity at myocardium (%) |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 65 | M | IC | LAD | 153 | 85 | 2.5 | 111.0 | 2.1 |
| 2 | 30 | M | IC | RCA | 5 | 477 | 7.5 | 111.0 | 2.7 |
| 3 | 58 | M | IC | LAD | 12 | 100 | 1.7 | 77.7 | 1.1 |
| 4 | 62 | M | IC | LAD | 7 | 114 | 3.1 | 148.0 | 3.3 |
| 5 | 59 | M | IC | LAD | 92 | 96 | 22 | 74.0 | 2.0 |
| 6 | 54 | M | IC | LAD | 8 | 847 | 57 | 37.0 | 0.5 |
| 7 | 71 | M | IC | LAD | 105 | 94 | 1.9 | 148.0 | 1.3 |
| 8 | 44 | M | IC | LAD | 3 | 1,611 | 242 | 148.0 | 1.0 |
| 9 | 71 | M | IC | LAD | 10 | 127 | 25 | 103.6 | 0.8 |
| 10 | 62 | M | IC | LAD | >300 | 84 | 6 | 99.9 | 0.2 |
| 11 | 43 | M | IC | RCA | 12 | 862 | 71.1 | 107.3 | 1.1 |
| 12 | 69 | F | IC | LAD | 6 | 5,027 | 279 | 355.2 | 1.3 |
| 13 | 43 | M | IC | LAD | 6 | 1,163 | 154 | 114.7 | 1.4 |
| 14 | 70 | F | IC | LAD | 5 | 1,165 | 204 | 125.8 | 1.4 |
| 15 | 64 | M | IC | LAD | 202 | 148 | 2.3 | 136.9 | 2.4 |
| 16 | 67 | F | IC | LCX | 40 | 97 | 4.2 | 155.4 | 1.4 |
| 17 | 56 | M | IC | RCA | 12 | 1,307 | 136.5 | 118.4 | 1.8 |
| 18 | 39 | M | IV | LAD | 7 | 702 | 81.5 | 177.6 | — |
| 19 | 74 | M | IV | LAD | 7 | 105 | 1.9 | 170.2 | — |
| 20 | 39 | M | IV | RCA | 7 | 3,004 | 200.5 | 214.6 | — |
CK = creatine kinase; CK-MB = creatine kinase isoenzyme containing M and B subunits; IC = intracoronary injection; LAD = left anterior descending artery; RCA = right coronary artery; LCX = left circumflex artery; IV = intravenous injection.